Alcon Shares in Switzerland Climb After Guidance Confirmation
By Adria Calatayud
Alcon shares in Switzerland rose after the eye-care specialist reported an acceleration in third-quarter sales growth and confirmed its annual outlook, reassuring on its prospects after two guidance cuts earlier in the year.
Zurich-listed shares in Alcon traded 6.3% higher in European morning trading, but are still down 15% since the start of the year.
The company said third-quarter net sales were $2.59 billion, up 6% on year and up 5% at constant currency. This compares with constant-currency growth of 3% for the second quarter.
Top-line growth was driven by an acceleration in its equipment segment, but Alcon reported higher sales across its businesses.
Quarterly net profit declined to $237 million from $263 million, which the company attributed to a higher tax bill.
Alcon maintained its full-year guidance for net sales, profitability and core earnings, having lowered expectations alongside its results for the first and second quarters.
"The outlook was confirmed, which is important after two profit warnings earlier this year. Alcon is launching several products to support growth, and the markets are improving," Vontobel analyst Sibylle Bischofberger wrote in a note to clients.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
November 12, 2025 04:09 ET (09:09 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
